Table 1: Patient information.

Diabetic Subjects Atrophy Prevalence Non-Diabetic Controls Atrophy Prevalence
C
2(3.9%)
N
6(11.8%)
S
43(84.3%)
p-value A
2(6.5%)
C
6(19.4%)
N
7(22.6%)
S
16(51.6%)
p-value
Pepsinogen I(µg/l) 26.65 ± 5.44 71.8 ± 9.9 125.1 ± 53.9 0.04 93.5 ± 36.9 18.6 ± 10.3 97.9 ± 60.0 110.5 ± 31.7
Gastrin-17 pmol/l 7.5 ± 0.0 3.9 ± 0.8 24.3 ± 19.2 0.02 0.1 ± 0.0 25.7 ± 26.6 8.8 ± 10.4 3.6 ± 2.5 0.01
Sex
Males
Females

0(0.0%)
2(100%)

2(33.3%)
4(66.7%)

14(32.6%)
29(67.4%)
0.62
1(50%)
1(50%)

2(33.3%)
4(66.7%)

5(71.4%)
2(28.6%)

10(62.5%)
6(37.5%)
0.03
Age(Yrs)

19 - 29
30 - 40
41 - 51
52 - 62
63 - 73
74 - 84
55.9 ± 9.8 40.3 ± 13.8 0.62
0(0.0%)
0(0%)
0(0%)
2(100%)
0(0%)
0(0%)
0(0%)
0(0%)
2(33.3%)
4(66.7%)
0(0%)
0(0%)
0(0.0%)
6(14.0%)
4(9.3%)
24(55.8%)
6(14.0%)
3(7.0%)
0.61 0(0%)
0(0%)
2(100%)
0(0%)
0(0%)
0(0%)
2(33.3%)
1(16.7%)
2(33.3%)
0(0%)
1(16.7%)
0(0%)
2(28.6%)
1(14.3%)
2(28.6%)
1(14.3%)
1(14.3%)
0(0%)
6(37.5%)
4(25.0%)
3(18.8%)
3(18.8%)
0(0%)
0(0%)
Dyspepsia
No
Yes

0
2(100%)

2(33.3%)
4(66.7%)

8(18.6%)
35(81.4%)
0.54
1(50%)
1(50%)

1(20%)
4(80%)

1(33.3%)
2(66.7%)

1(8.3%)
11(91.7%)
0.45